Position in GSK
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$343,875
-$13,480 QoQ
Shares Held
6,560
+1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#562
of 1,033 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARINO, STRAM & ASSOCIATES LLC holds $17,844,670 across 8 Drug Manufacturers - General names. GSK ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,721 | $3,738,692 | |
| 2 | LLY |
ELI LILLY & Co
|
3,091 | $3,707,438 | |
| 3 | ABBV |
AbbVie Inc.
|
13,846 | $3,484,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,413 | $3,137,070 | |
| 5 | AMGN |
Amgen Inc
|
5,457 | $1,976,088 | |
| 6 | PFE |
Pfizer Inc
|
31,798 | $765,695 | |
| 7 | NVS |
Novartis AG
|
4,413 | $691,605 | |
| 8 | GSK |
GSK plc
This page
|
6,560 | $343,875 |
All Filings in GSK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $343,875 | 6,560 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $357,355 | 6,475 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $313,708 | 6,397 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $276,051 | 6,396 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $238,387 | 6,208 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $238,987 | 6,169 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $207,215 | 6,127 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $249,245 | 6,097 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $233,348 | 6,061 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $214,564 | 5,005 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||